US Stock MarketDetailed Quotes

ALGS Aligos Therapeutics

Watchlist
  • 5.600
  • -0.435-7.21%
Close May 2 16:00 ET
  • 5.592
  • -0.008-0.15%
Post 18:50 ET
34.24MMarket Cap-0.27P/E (TTM)

Aligos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments
-58.04%56.94M
-58.04%56.94M
6.38%74.92M
4.07%94.54M
8.91%112.74M
7.85%135.7M
7.85%135.7M
-50.51%70.43M
-42.99%90.84M
-43.50%103.52M
-Cash and cash equivalents
-72.74%37M
-72.74%37M
-49.83%35.33M
-50.37%45.08M
-69.30%24.15M
66.82%135.7M
66.82%135.7M
-18.52%70.43M
27.62%90.83M
-24.76%78.67M
-Short-term investments
--19.94M
--19.94M
--39.59M
494,480.00%49.46M
256.56%88.59M
--0
--0
--0
-99.99%10K
-68.41%24.85M
Restricted cash
57.14%110K
57.14%110K
48.65%110K
66.67%70K
-45.59%216K
-39.13%70K
-39.13%70K
-7.50%74K
100.00%42K
-74.53%397K
Other current assets
-4.11%5.09M
-4.11%5.09M
15.70%4.79M
47.61%4.96M
-7.38%5.11M
-30.16%5.31M
-30.16%5.31M
-46.30%4.14M
-59.58%3.36M
-46.42%5.52M
Total current assets
-55.95%62.14M
-55.95%62.14M
6.94%79.82M
5.65%99.57M
7.89%118.06M
5.65%141.08M
5.65%141.08M
-50.27%74.64M
-43.80%94.24M
-43.90%109.43M
Non current assets
Net PPE
-25.38%7.33M
-25.38%7.33M
-24.72%7.97M
-23.56%8.61M
-21.10%9.21M
-21.54%9.82M
-21.54%9.82M
-20.54%10.59M
-20.81%11.26M
-20.98%11.68M
-Gross PPE
-7.12%19.11M
-7.12%19.11M
-8.48%19.51M
-8.24%19.9M
-4.96%20.62M
-6.83%20.57M
-6.83%20.57M
-4.70%21.32M
-4.58%21.69M
-4.47%21.7M
-Accumulated depreciation
-9.55%-11.78M
-9.55%-11.78M
-7.54%-11.54M
-8.31%-11.29M
-13.84%-11.41M
-12.41%-10.76M
-12.41%-10.76M
-18.64%-10.73M
-22.56%-10.43M
-26.27%-10.02M
Other non current assets
0.32%627K
0.32%627K
1.93%635K
1.12%631K
-1.11%625K
-1.42%625K
-1.42%625K
-4.59%623K
1.30%624K
2.60%632K
Total non current assets
-23.84%7.95M
-23.84%7.95M
-23.24%8.6M
-22.26%9.24M
-20.07%9.84M
-20.57%10.44M
-20.57%10.44M
-19.80%11.21M
-19.89%11.89M
-20.04%12.31M
Total assets
-53.74%70.09M
-53.74%70.09M
3.00%88.43M
2.53%108.81M
5.06%127.9M
3.30%151.53M
3.30%151.53M
-47.67%85.85M
-41.85%106.13M
-42.16%121.74M
Liabilities
Current liabilities
Payables
33.49%4.04M
33.49%4.04M
-1.68%9.75M
1.16%12.58M
-28.10%8.99M
-76.60%3.03M
-76.60%3.03M
-5.94%9.91M
9.07%12.43M
-31.01%12.5M
-accounts payable
2.15%2.57M
2.15%2.57M
-6.83%2.74M
110.40%6.82M
0.71%2.84M
-46.87%2.52M
-46.87%2.52M
0.34%2.94M
17.34%3.24M
-24.85%2.82M
-Other payable
187.87%1.47M
187.87%1.47M
0.49%7.01M
-37.36%5.76M
-36.49%6.15M
-93.77%511K
-93.77%511K
-8.36%6.97M
6.43%9.19M
-32.63%9.68M
Current accrued expenses
-20.28%7.7M
-20.28%7.7M
118.19%2.75M
87.86%2.71M
25.03%2.84M
555.67%9.66M
555.67%9.66M
38.05%1.26M
68.34%1.44M
98.69%2.27M
Current debt and capital lease obligation
6.76%3.46M
6.76%3.46M
4.45%3.4M
3.65%3.36M
3.97%3.27M
3.05%3.24M
3.05%3.24M
1.50%3.26M
10.33%3.24M
-4.43%3.15M
-Current capital lease obligation
6.76%3.46M
6.76%3.46M
4.45%3.4M
3.65%3.36M
3.97%3.27M
3.05%3.24M
3.05%3.24M
1.50%3.26M
10.33%3.24M
-4.43%3.15M
Current deferred liabilities
-88.46%151K
-88.46%151K
-83.42%655K
-80.93%1.33M
-89.74%721K
-85.80%1.31M
-85.80%1.31M
-63.17%3.95M
-47.06%6.95M
-53.36%7.03M
Other current liabilities
----
----
----
----
----
----
----
-91.95%7K
-80.92%25K
-76.04%46K
Current liabilities
-9.07%21.74M
-9.07%21.74M
-6.73%20.96M
-13.45%23.56M
-32.76%18.88M
-27.84%23.91M
-27.84%23.91M
-26.43%22.47M
-13.99%27.23M
-32.10%28.08M
Non current liabilities
Long term debt and capital lease obligation
-37.75%4.92M
-37.75%4.92M
-32.69%5.73M
-29.37%6.48M
-18.21%7.21M
-16.24%7.9M
-16.24%7.9M
-13.32%8.52M
-12.62%9.18M
-20.45%8.82M
-Long term capital lease obligation
-37.75%4.92M
-37.75%4.92M
-32.69%5.73M
-29.37%6.48M
-18.21%7.21M
-16.24%7.9M
-16.24%7.9M
-13.32%8.52M
-12.62%9.18M
-20.45%8.82M
Non current deferred liabilities
----
----
----
----
----
----
----
--0
-97.14%93K
-98.14%93K
Derivative product liabilities
162.24%72.37M
162.24%72.37M
--11.6M
--11.49M
--41.97M
--27.6M
--27.6M
----
----
----
Other non current liabilities
0.00%46K
0.00%46K
0.00%46K
--46K
--46K
--46K
--46K
-65.41%46K
----
----
Total non current liabilities
117.58%77.33M
117.58%77.33M
102.90%17.37M
94.37%18.02M
452.54%49.23M
267.77%35.54M
267.77%35.54M
-25.64%8.56M
-33.26%9.27M
-45.10%8.91M
Total liabilities
66.65%99.07M
66.65%99.07M
23.52%38.33M
13.94%41.58M
84.13%68.11M
38.92%59.45M
38.92%59.45M
-26.22%31.03M
-19.87%36.5M
-35.77%36.99M
Shareholders'equity
Share capital
14.29%8K
14.29%8K
100.00%8K
100.00%8K
75.00%7K
75.00%7K
75.00%7K
0.00%4K
0.00%4K
0.00%4K
-common stock
14.29%8K
14.29%8K
100.00%8K
100.00%8K
75.00%7K
75.00%7K
75.00%7K
0.00%4K
0.00%4K
0.00%4K
-Preferred stock
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Retained earnings
-26.95%-618.01M
-26.95%-618.01M
-16.77%-535.86M
-17.18%-516.6M
-23.59%-521.66M
-21.97%-486.8M
-21.97%-486.8M
-21.65%-458.91M
-22.94%-440.86M
-24.62%-422.07M
Paid-in capital
1.77%588.58M
1.77%588.58M
14.06%585.37M
14.38%583.33M
14.74%580.97M
15.06%578.33M
15.06%578.33M
2.83%513.23M
2.92%510M
3.04%506.32M
Gains losses not affecting retained earnings
-17.25%451K
-17.25%451K
16.10%577K
-0.60%494K
-4.61%476K
35.91%545K
35.91%545K
212.58%497K
894.00%497K
144.61%499K
Total stockholders'equity
-131.47%-28.97M
-131.47%-28.97M
-8.62%50.1M
-3.46%67.23M
-29.44%59.8M
-11.38%92.08M
-11.38%92.08M
-55.07%54.82M
-49.16%69.64M
-44.57%84.75M
Total equity
-131.47%-28.97M
-131.47%-28.97M
-8.62%50.1M
-3.46%67.23M
-29.44%59.8M
-11.38%92.08M
-11.38%92.08M
-55.07%54.82M
-49.16%69.64M
-44.57%84.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Assets
Current assets
Cash, cash equivalents and short term investments -58.04%56.94M-58.04%56.94M6.38%74.92M4.07%94.54M8.91%112.74M7.85%135.7M7.85%135.7M-50.51%70.43M-42.99%90.84M-43.50%103.52M
-Cash and cash equivalents -72.74%37M-72.74%37M-49.83%35.33M-50.37%45.08M-69.30%24.15M66.82%135.7M66.82%135.7M-18.52%70.43M27.62%90.83M-24.76%78.67M
-Short-term investments --19.94M--19.94M--39.59M494,480.00%49.46M256.56%88.59M--0--0--0-99.99%10K-68.41%24.85M
Restricted cash 57.14%110K57.14%110K48.65%110K66.67%70K-45.59%216K-39.13%70K-39.13%70K-7.50%74K100.00%42K-74.53%397K
Other current assets -4.11%5.09M-4.11%5.09M15.70%4.79M47.61%4.96M-7.38%5.11M-30.16%5.31M-30.16%5.31M-46.30%4.14M-59.58%3.36M-46.42%5.52M
Total current assets -55.95%62.14M-55.95%62.14M6.94%79.82M5.65%99.57M7.89%118.06M5.65%141.08M5.65%141.08M-50.27%74.64M-43.80%94.24M-43.90%109.43M
Non current assets
Net PPE -25.38%7.33M-25.38%7.33M-24.72%7.97M-23.56%8.61M-21.10%9.21M-21.54%9.82M-21.54%9.82M-20.54%10.59M-20.81%11.26M-20.98%11.68M
-Gross PPE -7.12%19.11M-7.12%19.11M-8.48%19.51M-8.24%19.9M-4.96%20.62M-6.83%20.57M-6.83%20.57M-4.70%21.32M-4.58%21.69M-4.47%21.7M
-Accumulated depreciation -9.55%-11.78M-9.55%-11.78M-7.54%-11.54M-8.31%-11.29M-13.84%-11.41M-12.41%-10.76M-12.41%-10.76M-18.64%-10.73M-22.56%-10.43M-26.27%-10.02M
Other non current assets 0.32%627K0.32%627K1.93%635K1.12%631K-1.11%625K-1.42%625K-1.42%625K-4.59%623K1.30%624K2.60%632K
Total non current assets -23.84%7.95M-23.84%7.95M-23.24%8.6M-22.26%9.24M-20.07%9.84M-20.57%10.44M-20.57%10.44M-19.80%11.21M-19.89%11.89M-20.04%12.31M
Total assets -53.74%70.09M-53.74%70.09M3.00%88.43M2.53%108.81M5.06%127.9M3.30%151.53M3.30%151.53M-47.67%85.85M-41.85%106.13M-42.16%121.74M
Liabilities
Current liabilities
Payables 33.49%4.04M33.49%4.04M-1.68%9.75M1.16%12.58M-28.10%8.99M-76.60%3.03M-76.60%3.03M-5.94%9.91M9.07%12.43M-31.01%12.5M
-accounts payable 2.15%2.57M2.15%2.57M-6.83%2.74M110.40%6.82M0.71%2.84M-46.87%2.52M-46.87%2.52M0.34%2.94M17.34%3.24M-24.85%2.82M
-Other payable 187.87%1.47M187.87%1.47M0.49%7.01M-37.36%5.76M-36.49%6.15M-93.77%511K-93.77%511K-8.36%6.97M6.43%9.19M-32.63%9.68M
Current accrued expenses -20.28%7.7M-20.28%7.7M118.19%2.75M87.86%2.71M25.03%2.84M555.67%9.66M555.67%9.66M38.05%1.26M68.34%1.44M98.69%2.27M
Current debt and capital lease obligation 6.76%3.46M6.76%3.46M4.45%3.4M3.65%3.36M3.97%3.27M3.05%3.24M3.05%3.24M1.50%3.26M10.33%3.24M-4.43%3.15M
-Current capital lease obligation 6.76%3.46M6.76%3.46M4.45%3.4M3.65%3.36M3.97%3.27M3.05%3.24M3.05%3.24M1.50%3.26M10.33%3.24M-4.43%3.15M
Current deferred liabilities -88.46%151K-88.46%151K-83.42%655K-80.93%1.33M-89.74%721K-85.80%1.31M-85.80%1.31M-63.17%3.95M-47.06%6.95M-53.36%7.03M
Other current liabilities -----------------------------91.95%7K-80.92%25K-76.04%46K
Current liabilities -9.07%21.74M-9.07%21.74M-6.73%20.96M-13.45%23.56M-32.76%18.88M-27.84%23.91M-27.84%23.91M-26.43%22.47M-13.99%27.23M-32.10%28.08M
Non current liabilities
Long term debt and capital lease obligation -37.75%4.92M-37.75%4.92M-32.69%5.73M-29.37%6.48M-18.21%7.21M-16.24%7.9M-16.24%7.9M-13.32%8.52M-12.62%9.18M-20.45%8.82M
-Long term capital lease obligation -37.75%4.92M-37.75%4.92M-32.69%5.73M-29.37%6.48M-18.21%7.21M-16.24%7.9M-16.24%7.9M-13.32%8.52M-12.62%9.18M-20.45%8.82M
Non current deferred liabilities ------------------------------0-97.14%93K-98.14%93K
Derivative product liabilities 162.24%72.37M162.24%72.37M--11.6M--11.49M--41.97M--27.6M--27.6M------------
Other non current liabilities 0.00%46K0.00%46K0.00%46K--46K--46K--46K--46K-65.41%46K--------
Total non current liabilities 117.58%77.33M117.58%77.33M102.90%17.37M94.37%18.02M452.54%49.23M267.77%35.54M267.77%35.54M-25.64%8.56M-33.26%9.27M-45.10%8.91M
Total liabilities 66.65%99.07M66.65%99.07M23.52%38.33M13.94%41.58M84.13%68.11M38.92%59.45M38.92%59.45M-26.22%31.03M-19.87%36.5M-35.77%36.99M
Shareholders'equity
Share capital 14.29%8K14.29%8K100.00%8K100.00%8K75.00%7K75.00%7K75.00%7K0.00%4K0.00%4K0.00%4K
-common stock 14.29%8K14.29%8K100.00%8K100.00%8K75.00%7K75.00%7K75.00%7K0.00%4K0.00%4K0.00%4K
-Preferred stock --0--0--0--0--0--0--0--0--0--0
Retained earnings -26.95%-618.01M-26.95%-618.01M-16.77%-535.86M-17.18%-516.6M-23.59%-521.66M-21.97%-486.8M-21.97%-486.8M-21.65%-458.91M-22.94%-440.86M-24.62%-422.07M
Paid-in capital 1.77%588.58M1.77%588.58M14.06%585.37M14.38%583.33M14.74%580.97M15.06%578.33M15.06%578.33M2.83%513.23M2.92%510M3.04%506.32M
Gains losses not affecting retained earnings -17.25%451K-17.25%451K16.10%577K-0.60%494K-4.61%476K35.91%545K35.91%545K212.58%497K894.00%497K144.61%499K
Total stockholders'equity -131.47%-28.97M-131.47%-28.97M-8.62%50.1M-3.46%67.23M-29.44%59.8M-11.38%92.08M-11.38%92.08M-55.07%54.82M-49.16%69.64M-44.57%84.75M
Total equity -131.47%-28.97M-131.47%-28.97M-8.62%50.1M-3.46%67.23M-29.44%59.8M-11.38%92.08M-11.38%92.08M-55.07%54.82M-49.16%69.64M-44.57%84.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion------------------

Market Insights

Best Growth Stocks Best Growth Stocks

Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

Unlock Now

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More

Reassessing Chinese Assets

Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.